Literature DB >> 31233125

Breast Cancer Screening in High-Risk Women: Is MRI Alone Enough?

Carolina Rossi Saccarelli1,2, Almir G V Bitencourt1,3, Elizabeth A Morris1.   

Abstract

Entities:  

Year:  2020        PMID： 31233125      PMCID： PMC7019094          DOI： 10.1093/jnci/djz130

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  12 in total

1.  Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.

Authors:  Anna M Chiarelli; Kristina M Blackmore; Derek Muradali; Susan J Done; Vicky Majpruz; Ashini Weerasinghe; Lucia Mirea; Andrea Eisen; Linda Rabeneck; Ellen Warner
Journal:  J Natl Cancer Inst       Date:  2020-02-01       Impact factor: 13.506

2.  Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis.

Authors:  Xuan-Anh Phi; Marcel J W Greuter; Inge-Marie Obdeijn; Jan C Oosterwijk; Talitha L Feenstra; Nehmat Houssami; Geertruida H de Bock
Journal:  Breast       Date:  2019-03-12       Impact factor: 4.380

3.  Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Digital Mammography: Evaluation in a Population-based Screening Program.

Authors:  Solveig Hofvind; Tone Hovda; Åsne S Holen; Christoph I Lee; Judy Albertsen; Hilde Bjørndal; Siri H B Brandal; Randi Gullien; Jon Lømo; Daehoon Park; Linda Romundstad; Pål Suhrke; Einar Vigeland; Per Skaane
Journal:  Radiology       Date:  2018-03-01       Impact factor: 11.105

4.  Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.

Authors:  Rodrigo Santa Cruz Guindalini; Yonglan Zheng; Hiroyuki Abe; Kristen Whitaker; Toshio F Yoshimatsu; Tom Walsh; David Schacht; Kirti Kulkarni; Deepa Sheth; Marion S Verp; Angela R Bradbury; Jane Churpek; Elias Obeid; Jeffrey Mueller; Galina Khramtsova; Fang Liu; Akila Raoul; Hongyuan Cao; Iris L Romero; Susan Hong; Robert Livingston; Nora Jaskowiak; Xiaoming Wang; Marcio Debiasi; Colin C Pritchard; Mary-Claire King; Gregory Karczmar; Gillian M Newstead; Dezheng Huo; Olufunmilayo I Olopade
Journal:  Clin Cancer Res       Date:  2018-08-28       Impact factor: 12.531

5.  Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.

Authors:  Christopher C Riedl; Nikolaus Luft; Clemens Bernhart; Michael Weber; Maria Bernathova; Muy-Kheng M Tea; Margaretha Rudas; Christian F Singer; Thomas H Helbich
Journal:  J Clin Oncol       Date:  2015-02-23       Impact factor: 44.544

6.  Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study.

Authors:  Anand K Narayan; Kala Visvanathan; Susan C Harvey
Journal:  Breast Cancer Res Treat       Date:  2016-07-21       Impact factor: 4.872

7.  BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials.

Authors:  Madeleine M A Tilanus-Linthorst; Inge-Marie Obdeijn; Wim C J Hop; Petrina A Causer; Martin O Leach; Ellen Warner; Linda Pointon; Kimberley Hill; Jan G M Klijn; Ruth M L Warren; Fiona J Gilbert
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

Review 8.  Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.

Authors:  Xuan-Anh Phi; Nehmat Houssami; Maartje J Hooning; Christopher C Riedl; Martin O Leach; Francesco Sardanelli; Ellen Warner; Isabelle Trop; Sepideh Saadatmand; Madeleine M A Tilanus-Linthorst; Thomas H Helbich; Edwin R van den Heuvel; Harry J de Koning; Inge-Marie Obdeijn; Geertruida H de Bock
Journal:  Eur J Cancer       Date:  2017-11       Impact factor: 9.162

9.  Abbreviated MRI of the Breast: Does It Provide Value?

Authors:  Doris Leithner; Linda Moy; Elizabeth A Morris; Maria A Marino; Thomas H Helbich; Katja Pinker
Journal:  J Magn Reson Imaging       Date:  2018-09-08       Impact factor: 4.813

10.  Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).

Authors:  Anouk Pijpe; Nadine Andrieu; Douglas F Easton; Ausrele Kesminiene; Elisabeth Cardis; Catherine Noguès; Marion Gauthier-Villars; Christine Lasset; Jean-Pierre Fricker; Susan Peock; Debra Frost; D Gareth Evans; Rosalind A Eeles; Joan Paterson; Peggy Manders; Christi J van Asperen; Margreet G E M Ausems; Hanne Meijers-Heijboer; Isabelle Thierry-Chef; Michael Hauptmann; David Goldgar; Matti A Rookus; Flora E van Leeuwen
Journal:  BMJ       Date:  2012-09-06
View more
  1 in total

1.  Radiomic signatures derived from multiparametric MRI for the pretreatment prediction of response to neoadjuvant chemotherapy in breast cancer.

Authors:  Tiantian Bian; Zengjie Wu; Qing Lin; Haibo Wang; Yaqiong Ge; Shaofeng Duan; Guangming Fu; Chunxiao Cui; Xiaohui Su
Journal:  Br J Radiol       Date:  2020-09-02       Impact factor: 3.039
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.